Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,032

Document Document Title
WO/2018/012459A1
An oxygen separation membrane which is configured of a porous material and a complex in the form of a liquid, said complex being internally contained in the porous material, and wherein: the complex contains a metal salen complex or a de...  
WO/2018/003587A1
Provided are: a method for easily producing, with a high yield, an iron binuclear complex having a structure in which two iron atoms are bonded together through one oxygen atom, and a ligand structure containing a Shiff base, in the mole...  
WO/2017/221586A1
A vanadium compound represented by general formula (1). In general formula (1), R1 represents a linear or branched alkyl group having 1-7 carbon atoms, and preferably represents a secondary alkyl group or a tertiary alkyl group; and n re...  
WO/2017/217553A1
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] An oxime compound represented by formula (1) and an herbicide containing the same. (In formula (1): B represents B-1 or the like; Q represents ...  
WO/2017/214680A1
The present invention relates to new multi-functional compounds that are useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease, to the preparation of the compounds, and to compositions including the compounds...  
WO/2017/192691A1
Provided herein is a cell culture medium and methods of using thereof. The cell culture medium generally comprises a compound (e.g., a bromodomain inhibitor) that can enhance product titer, cell viability, cell specific productivity, and...  
WO/2017/169819A1
A black photosensitive resin composition which contains: a photopolymerization initiator composition (A) that contains 1-99 parts by mass of the component (A-1) described below and 1-99 parts by mass of the component (A-2) described belo...  
WO/2017/149640A1
One purpose of the present invention is to provide a liquid crystalline compound which exhibits liquid crystallinity at low temperatures. Another purpose of the present invention is to provide: a thermally responsive material which exhib...  
WO/2017/146581A1
Described are methods for preparing phenols, benzene carboxylic acids, esters and anhydrides thereof from furanic compounds by reaction with a dienophile, wherein the furanic compounds are reacted with a hydrazine and/or oxime and then r...  
WO/2017/133942A1
The present invention relates to a catalytic process for preparing pyrazoles comprising the step of cyclizing hydrazone substituted α,β-unsaturated carbonyl compounds by reacting them with hydrogen in a reaction mixture comprising as c...  
WO/2017/119515A1
An object of the present invention is to provide a novel ascochlorin derivative which activates adenosine monophosphate-activated protein kinase (AMPK), and is useful in the treatment or prevention of diseases or conditions that involve ...  
WO/2017/111176A1
Synthesis of an organic compound with chirality is an important technique in the fields of medicines, pesticides, health foods, etc. However, catalysts to be used for such synthesis are produced from expensive starting materials and, fur...  
WO/2017/102659A1
The invention relates to a method for synthesising at least one nitrogen compound belonging to the family of the partially N-hydroxyethylated tertiary 1,6-hexanediamines of the following general formula (I) in which the groups R1, R2 and...  
WO/2017/105999A1
Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, (Formula 1) wherein Z, Q, R1, R2, R3, R4 and m are as defined in the disclosure. Also disclosed are compositions containing the...  
WO/2017/106520A1
Disclosed are compounds of formulas I and II, in which R, R0, R1-R4, R7-R10, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds. The compounds and pharmaceutical compositions are for use in ...  
WO/2017/100644A1
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a ribonucleotide reductase modulator (RRmod), the amount being effective to inhibit neoplastic cell growth.  
WO/2017/085747A2
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/085747A4
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/085747A3
The present invention relates to a novel process for preparation of methyl (αE)-(α- (methoxyimino)-2-[[[(E)-[1-[3- (trifluoromethyl) phenyl] ethylidene] amino] oxy] methyl] benzeneaceate (Trifloxystrobin) compound of formula (I) in fre...  
WO/2017/082144A1
The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt or prodrug thereof. The present invention also provides: a composition which includes the compound represented by formula (I), or...  
WO/2017/076771A1
The present invention relates to selected acylhydrazone compounds, their use as oxidation catalysts and to a process for removing stains and soil on textiles and hard surfaces. The compounds contain two acylhydrazone groups per molecule ...  
WO/2017/067497A3
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...  
WO/2017/068860A1
The present invention provides a compound represented by general formula (I) and a polymerizable composition containing said compound. A polymerizable composition containing a compound represented by general formula (I), when used to pro...  
WO/2017/066421A1
Provided are methods of treating cognitive impairment and/or psychosis and/or movement disorders by administering a pharmaceutical composition of eplivanserin or a pharmaceutically acceptable salt thereof to a subject in need thereof.  
WO/2017/059772A1
Disclosed are a photoinitiator containing a fluorene oxime ester, as shown by the following formula (I), synthesis therefor, a photosensitive resin composition containing same, and a use thereof. The compound is simple in synthesis and l...  
WO/2017/054112A1
The present invention relates to a method of preparing a 3-fluoroalkyl-1-methylpyrazole-4-carboxylic acid comprising the following steps: Step 1, performing a condensation reaction on the fluoroacetyl halide derivative shown in formula I...  
WO/2017/052351A1
The present invention provides: an oxime ester compound, which is suitable for use as a photoinitiator for high-brightness materials and transparent materials and has excellent thermal stability and solubility in an organic solvent; and ...  
WO/2017/043620A1
The present invention relates to a chemical vapor deposition feedstock for manufacturing a ruthenium thin film or ruthenium compound thin film by chemical vapor deposition, the chemical vapor deposition feedstock comprising an organic ru...  
WO/2017/041642A1
Provided is a compound based on a meta-linked bihydrazinoazine structure and a preparation method and a use thereof. The compound can be used as a red probe and has an excellent aggregation-induced luminescence property, and can be used ...  
WO/2017/036436A1
The present invention provides primin derivatives of general formula II and/or III, wherein R1 is selected from the group consisting of methyl and hydrogen, R2 is selected from the group consisting of methoxy, hydroxy, hydrogen, R3 is se...  
WO/2017/040518A1
A method for etching silicon-containing films is disclosed. The method includes the steps of introducing a vapor of a nitrogen containing etching compound into a reaction chamber containing a silicon-containing film on a substrate, where...  
WO/2017/033880A1
An oxime ester compound represented by general formula (I). In general formula (I), at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 is a group represented by general formula (II). The oxime ester compound preferably contains ...  
WO/2017/024971A1
Provided are an unsaturated oximino ether compound and a use thereof. The compound is as shown by general formula I, wherein the compound of formula I has an excellent bactericidal activity, and especially still has good control effect o...  
WO/2017/004734A1
Disclosed are a compound represented by formula I, a preparation method therefor, and a use thereof. See the specification for the definition of each substituent group in formula I. The preparation method comprises the following step: pe...  
WO/2017/006573A1
A side chain precursor of paclitaxel and docetaxel is provided at high purity, high yield, and low cost through a method for producing a compound shown by formula (3) using a compound shown by formula (1) as a starting compound. Using th...  
WO/2016/207167A1
The present invention relates to a novel process for preparing 3,5 -bis substituted pyrazoles containing haloalkoxy- and haloalkylthio groups.  
WO/2016/199706A1
A power supply device, a photochemical reaction device and method in which the power supply device is used, and a lactam production method in which the photochemical reaction method is used, said power supply device being characterized i...  
WO/2016/192610A1
The present invention provides a compound having a novel acyloxime ester structure of the structure shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable s...  
WO/2016/192611A1
The present invention provides a compound having an acyloxime ester structure of the structural shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable solub...  
WO/2016/190280A1
[Problem] To provide a method for efficiently producing an O-[1-(2-hydroxypropyl)]oxime compound at low cost, said O-[1-(2-hydroxypropyl)]oxime compound having extremely high purity and being suitable as an intermediate for pharmaceutica...  
WO/2016/179910A1
The present invention relates to a solvent-free green ammoximation process based on film distribution, which comprises: adding a TS-1 catalyst and a ketone into a reactor in advance, setting a stirring speed and a reaction temperature, a...  
WO/2016/181917A1
The present invention relates to a chemical vapor deposition starting material represented below that comprises a heterogeneous polynuclear complex in which at least a diimine and carbonyl are coordinated, as ligands, to a first transiti...  
WO/2016/154694A1
The present invention relates to N-acylhydrazone derivatives with histone deacetylase enzyme inhibiting activity, to anti-tumour pharmaceutical compositions that comprise said compounds, and to methods for producing the same. The present...  
WO/2016/143456A1
A diazadienyl compound represented by general formula (I). (In the formula, R1 and R2 each independently represent a linear or branched alkyl group having 1-6 carbon atoms, R3 represents a hydrogen atom or a linear or branched alkyl grou...  
WO/2016/140587A1
Method for preparation of 5-alkylsalicylaldoximes with formula 1, where R is a C6-C16 alkyl group, consisting in that into a water- alcohol solvent system, p-alkylphenol, sodium hydroxide, chloroform and hydroxylamine are introduced, whi...  
WO/2016/136533A1
The present invention provides a polymerizable compound which does not cause precipitation of a crystal or the like when added into a polymerizable composition, and which has high storage stability. In addition, an objective of the prese...  
WO/2016/124127A1
A photosensitive resin composition, containing ultraviolet photosensitive prepolymer resin, an active diluting monomer, an oxime ester photoinitiator represented by formula (I), and a colorant. The composition has good exposure sensibili...  
WO/2016/126207A1
Provided herein a vanadium(V) complex of formula I, where R1 to R8 are as defined herein. Also provided herein are reactions making use of the vanadium(V) complex of formula I, such as selective sp3-sp3 carbon-carbon bond cleavage under ...  
WO/2016/126070A1
The present invention relates to a novel oximester derivative compound, and a photopolymerization initiator and photoresist composition containing the same. Specifically, the oximester derivative compound according to the present inventi...  
WO/2016/122160A1
The present invention relates to a novel dioximester compound, and a photopolymerization initiator and photoresist composition containing the same.  

Matches 1 - 50 out of 7,032